Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Malignant Melanoma|Breast Cancer
Interventions: BIOLOGICAL: T cells modified with RNA anti -cMET CAR
Sponsor: University of Pennsylvania